Mevo Raises $18M Round Led by Prosus

Why It Matters

The investment underscores growing confidence in Latin America’s health‑tech sector and positions Mevo to deepen its ecosystem, potentially reshaping digital care delivery in Brazil’s sizable private market.

Key Takeaways

• Mevo serves 30% of Brazil's private healthcare market
• Platform now includes exam scheduling and online pharmacy
• Funding will accelerate patient support program integration
• Prosus leads round, signaling confidence in Latin health tech
• Over 1,100 institutions and 11 pharmacy chains already connected

Pulse Analysis

Brazil’s private healthcare market is rapidly digitizing, driven by rising demand for telemedicine, streamlined prescription workflows, and integrated patient services. Mevo, founded in 2017, has emerged as a central hub connecting doctors, patients, insurers, and pharmacies, leveraging a platform that now supports exam scheduling and online medication fulfillment. By covering roughly a third of the private sector, the company is well‑positioned to benefit from the country’s projected $30 billion health‑tech spend by 2028, as providers seek efficiency and patients demand convenience.

The $18 million round, led by global tech investor Prosus, signals a broader shift of capital toward Latin American health‑tech innovators. Prosus’s involvement brings not only financial resources but also strategic expertise in scaling digital platforms across emerging markets. This aligns with a trend where multinational venture firms are targeting Brazil’s large, under‑served population to capture early‑stage growth, mirroring similar investments in Brazil’s fintech and e‑commerce sectors. The participation of Matrix, Jefferson River Capital, and Floating Point further validates Mevo’s business model and growth trajectory.

Looking ahead, Mevo’s expanded capabilities—particularly in patient‑support programs and its online pharmacy—could streamline care pathways, reduce prescription errors, and improve medication adherence. As the platform integrates deeper with insurers and expands its retail footprint, it may set new standards for end‑to‑end digital health experiences in the region. Competitors will need to match Mevo’s breadth of services or risk losing market share, while regulators will watch closely to ensure data security and patient safety in this increasingly connected ecosystem.